PIEZO1 and central nervous system cancer: Having established that PIEZO1 is a primary actuator responsible for NLGN3-mediated shedding of CSPG4, we hypothesized that blocking the PIEZO1 response in glioma would mimic loss of microenvironmental NLGN3 and affect glioma growth in vivo2,3.